Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

119.01
Delayed Data
As of 4:00pm ET
 -0.36 / -0.30%
Today’s Change
96.18
Today|||52-Week Range
149.34
-0.48%
Year-to-Date

Today’s Trading

Previous close119.37
Today’s open119.59
Day’s range118.34 - 120.16
Volume798,792
Average volume (3 months)2,118,498
Market cap$27.3B
Data as of 4:00pm ET, 05/22/2018

Growth & Valuation

Earnings growth (last year)+11.93%
Earnings growth (this year)+18.62%
Earnings growth (next 5 years)+17.29%
Revenue growth (last year)+17.32%
P/E ratio51.0
Price/Sales7.63
Price/Book3.07

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-1.00-1.17%
BAXBaxter International...-0.38-0.53%
INCYIncyte Corp-0.23-0.34%
VRTXVertex Pharmaceutica...+0.06+0.04%
Data as of 4:00pm ET, 05/22/2018

Financials

Next reporting dateJuly 26, 2018
EPS forecast (this quarter)$1.69
Annual revenue (last year)$3.5B
Annual profit (last year)$443.3M
Net profit margin12.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts